Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02908061 · ClinicalTrials.gov registry record · Phase 3

A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia

A Phase 3 study of Radical Cystectomy, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
Phase 3
Development phase
178
Enrollment target
7
Study locations

NCT02908061: Active Phase 3 study of Radical Cystectomy, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02908061 is a Phase 3 study of Radical Cystectomy that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 178 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02908061, a Phase 3 study of Radical Cystectomy, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
178 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to compare any good and bad effects of using Ultrapro mesh along with the usual bladder removal surgery, versus having the usual bladder removal surgery without the use of the mesh.

Conditions Studied

Interventions

  • PROCEDURE Surgery Radical Cystectomy
  • PROCEDURE Ultrapro mesh

Study Locations (7)

New York

  • Memorial Sloan Kettering Commack (Consent and follow-up only) - Commack
  • Memorial Sloan Kettering Westchester (Consent and follow-up only) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Consent only and Follow Up) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Consent and follow-up only) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent and follow-up only) - Montvale

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2016-08
Est. Completion 2026-08
Phase Phase 3
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT02908061 still lists

NCT02908061 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Radical Cystectomy appearing as the primary indexed condition, and to 2 interventions - of which Surgery Radical Cystectomy is the first listed.

NCT02908061 lists 7 locations in 2 states (New York, New Jersey).

Frequently Asked Questions

What is clinical trial NCT02908061 about?

NCT02908061 is a clinical study titled "A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia". The purpose of this study is to compare any good and bad effects of using Ultrapro mesh along with the usual bladder removal surgery, versus having the usual bladder removal surgery without the use of the mesh.

What is the current status of trial NCT02908061?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 178 participants. The study started on 2016-08. Estimated completion is 2026-08.

What conditions does trial NCT02908061 study?

This clinical trial studies the following conditions: Radical Cystectomy.

What interventions are being tested in trial NCT02908061?

The interventions under investigation include: Surgery Radical Cystectomy (PROCEDURE), Ultrapro mesh (PROCEDURE).

Who is sponsoring clinical trial NCT02908061?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02908061 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Radical Cystectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02908061's enrollment target sits among peer trials

178 1438th of 2000 higher than 563 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03642002 · 178 participants · NA

    The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

  • NCT04227847 · 178 participants · Phase 1

    A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

  • NCT04855214 · 178 participants

    Evaluating the Experience of Upper Limb Prosthesis Use

  • NCT05391126 · 178 participants · NA

    GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02908061, the US trial registry maintained by the National Library of Medicine. NCT02908061 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.